Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox

Chronic kidney disease (CKD) concerns millions of individuals worldwide, with few therapeutic strategies available to date. Recent evidence suggests that the endocannabinoid system (ECS) could be a new therapeutic target to prevent CKD. ECS combines receptors, cannabinoid receptor type 1 (CB1R) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Dao, Myriam, François, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293381/
https://www.ncbi.nlm.nih.gov/pubmed/34305821
http://dx.doi.org/10.3389/fendo.2021.720734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293381/
https://www.ncbi.nlm.nih.gov/pubmed/34305821
http://dx.doi.org/10.3389/fendo.2021.720734

Ejemplares similares